Skip to main content
Log in

CML much higher treatment cost than other haematological cancers

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wilkes JJ, et al. Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies. JCO Oncology Practice : 21 Aug 2020. Available from: URL: https://doi.org/10.1200/OP.20.00143

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

CML much higher treatment cost than other haematological cancers. PharmacoEcon Outcomes News 861, 9 (2020). https://doi.org/10.1007/s40274-020-7091-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7091-z

Navigation